A NEW type of fat jab is being trialled on humans for the first time. Inventors claim they can modify RNA genetic material to rewire the metabolism and aid weight loss without dieting. The ...

Compared with usual care, GLP-1 receptor agonists tirzepatide and semaglutide may be cost-effective options for patients with ...

Learn how Orforglipron oral GLP-1 pill treats obesity and type 2 diabetes, supporting weight loss and glucose control. Discover benefits today!

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% ...

Paris, France, Thursday, 18 September 2025) Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower ...

Novo Nordisk NVO announced positive data from a sub-analysis of its phase III REDEFINE 1 study assessing the efficacy and ...

The once-daily oral GLP-1 RA orforglipron produces clinically and statistically significant weight loss and cardiometabolic ...

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight ...

GLP-1 receptor agonists like Ozempic can be a lifeline for people with diabetes - helping stabilize blood glucose and lose ...

The competition to develop obesity treatments that are more convenient and powerful than Wegovy and Mounjaro is intensifying. Since the popularization ...